HomeSafetyGallbladder risk

Safety topic

GLP-1 medications and gallbladder events (cholelithiasis)

Rapid weight loss of any kind increases gallstone risk; GLP-1 trials show ~1-3% incidence of cholelithiasis vs ~0.5% placebo. The risk is weight-loss mediated, not drug-specific.

Real, documented risk

Who should not take this

  • Active acute cholecystitis
  • Recent gallstone-induced pancreatitis (within 6 months)

How it happens

Rapid weight loss + reduced bile flow + altered cholesterol saturation create the classic gallstone-formation environment. STEP-1 (semaglutide) reported gallbladder-related adverse events in 2.6% of treated patients vs 1.2% placebo; SURMOUNT-1 (tirzepatide) reported 2.0% vs 0.4% placebo.

Red flags — when to seek care

  • Persistent right-upper-quadrant pain
  • Pain after fatty meals that lasts hours
  • Yellowing of skin or eyes (jaundice)
  • Fever with abdominal pain

What to do

  1. 1.Report persistent RUQ pain or post-meal pain to your prescriber
  2. 2.Standard workup is ultrasound + LFTs
  3. 3.Mitigation strategies: gradual weight loss (≤1-2 lb/week), maintained protein intake, occasional dietary fat (very-low-fat diets accelerate stone formation)

Affected medications

Sources

People also ask

Common questions readers ask

Can you drink alcohol on Wegovy?
No hard contraindication, but alcohol tolerance often drops sharply on GLP-1. Many patients also report reduced desire for alcohol — likely a secondary effect of GLP-1 on the brain reward system.
Full evidence-graded answer
Does GLP-1 affect oral birth control?
Tirzepatide (Mounjaro, Zepbound) has documented reduced absorption of oral contraceptives during the first 4 weeks of each dose increase. Use backup contraception for ~4 weeks after starting + after each step-up. Semaglutide has no documented effect.
Full evidence-graded answer
Can I take GLP-1 while pregnant?
No. All FDA-approved GLP-1s carry a pregnancy contraindication. Stop GLP-1 at least 2 months before planned conception due to its long half-life.
Full evidence-graded answer
Is it safe to take GLP-1 long-term?
Liraglutide has 15+ years of post-marketing data (Victoza approved 2010). Semaglutide has 8+ years (Ozempic approved 2017). No new class-wide safety signals have emerged in extended follow-up. Chronic use is the FDA-approved indication for both T2D and obesity.
Full evidence-graded answer

Editorial information based on FDA prescribing data + peer-reviewed sources as of 2026. Not personal medical advice. Reviewed by Jane Novak, MD, MPH.